Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.
Saved in:
| Title: | Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group. |
|---|---|
| Authors: | Masuda H; Department of Breast Surgical Oncology, School of Medicine, Showa University, Tokyo, Japan., Nagai SE; Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan., Hattori M; Aichi Breast Clinic Hirabari, Nagoya, Japan.; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan., Yoshinami T; Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan., Okamura T; Department of Breast Oncology, Tokai University School of Medicine, Kanagawa, Japan., Watanabe K; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan., Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan., Takabatake D; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Harao M; Department of Breast Oncology, Jichi Medical University, Shimotsuke, Japan., Yoshino H; Breast and Endocrinological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan., Mori N; Department of Breast Surgery, Seirei Hamamatsu General Hospital, Hamamatsu, Japan., Yasojima H; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Oshiro C; Department of Breast Surgery, Kaizuka City Hospital, Osaka, Japan., Iwase M; Department of Breast and Endocrine Surgery, Nagoya University Hospital, Nagoya, Japan., Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan., Sangai T; Department of Breast and Thyroid Surgery, Kitasato University School of Medicine, Sagamihara, Japan., Sasada S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Ishida T; Division of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan., Futamura M; Department of Breast Surgery, Gifu University Hospital, Gifu, Japan., Oda H; Oncology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan., Muramatsu Y; Oncology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan., Masuda N; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. nmasuda@alpha.ocn.ne.jp. |
| Source: | Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Mar; Vol. 33 (2), pp. 333-345. Date of Electronic Publication: 2026 Feb 11. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
